全文获取类型
收费全文 | 656篇 |
免费 | 55篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 23篇 |
妇产科学 | 20篇 |
基础医学 | 47篇 |
口腔科学 | 11篇 |
临床医学 | 86篇 |
内科学 | 137篇 |
皮肤病学 | 22篇 |
神经病学 | 16篇 |
特种医学 | 102篇 |
外科学 | 75篇 |
综合类 | 24篇 |
预防医学 | 43篇 |
眼科学 | 14篇 |
药学 | 35篇 |
中国医学 | 2篇 |
肿瘤学 | 49篇 |
出版年
2023年 | 7篇 |
2021年 | 19篇 |
2020年 | 8篇 |
2019年 | 6篇 |
2018年 | 15篇 |
2017年 | 17篇 |
2016年 | 11篇 |
2015年 | 20篇 |
2014年 | 32篇 |
2013年 | 47篇 |
2012年 | 21篇 |
2011年 | 24篇 |
2010年 | 37篇 |
2009年 | 24篇 |
2008年 | 23篇 |
2007年 | 23篇 |
2006年 | 14篇 |
2005年 | 12篇 |
2004年 | 15篇 |
2003年 | 9篇 |
2002年 | 12篇 |
2001年 | 17篇 |
2000年 | 6篇 |
1999年 | 15篇 |
1998年 | 25篇 |
1997年 | 32篇 |
1996年 | 29篇 |
1995年 | 17篇 |
1994年 | 19篇 |
1993年 | 12篇 |
1992年 | 11篇 |
1991年 | 2篇 |
1990年 | 6篇 |
1989年 | 10篇 |
1988年 | 8篇 |
1987年 | 8篇 |
1986年 | 9篇 |
1985年 | 10篇 |
1984年 | 9篇 |
1983年 | 5篇 |
1982年 | 13篇 |
1981年 | 8篇 |
1980年 | 12篇 |
1979年 | 5篇 |
1978年 | 6篇 |
1977年 | 8篇 |
1976年 | 6篇 |
1975年 | 5篇 |
1973年 | 3篇 |
1970年 | 2篇 |
排序方式: 共有716条查询结果,搜索用时 171 毫秒
711.
T Yasuda H Imai Y Nakamoto H Ohtani A Komatsuda H Wakui AB Miura 《American journal of kidney diseases》1999,33(1):123-127
Collagenofibrotic glomerulopathy is a recently discovered entity that is characterized by massive accumulation of spiraled and frayed collagen fibrils in mesangial and subendothelial areas, and elevated serum levels of procollagen III peptide. We report the autopsy of a patient who received continuous ambulatory peritoneal dialysis (CAPD) therapy for 7 years. Autopsy disclosed that massive accumulation of peculiar collagen fibers was found not only in the kidney, but also in many organs including spleen, liver, myocardium, and thyroid gland. Although the possibility remains that CAPD for 7 years might change or aggravate the deposition of abnormal collagen, the current case suggests a possibility that collagenofibrotic glomerulopathy is a systemic disorder with abnormal metabolism of type III collagen. 相似文献
712.
Maria Hassan Tanveer Hussain Bokhari Nadeem Ahmed Lodhi Muhammad Kaleem Khosa Muhammad Usman 《Chemical biology & drug design》2023,102(5):1276-1292
In nuclear medicine, cancers that cannot be cured or can only be treated partially by traditional techniques like surgery or chemotherapy are killed by ionizing radiation as a form of therapeutic treatment. Actinium-225 is an alpha-emitting radionuclide that is highly encouraging as a therapeutic approach and more promising for targeted alpha therapy (TAT). Actinium-225 is the best candidate for tumor cells treatment and has physical characteristics such as high (LET) linear energy transfer (150 keV per μm), half-life (t1/2 = 9.92d), and short ranges (400–100 μm) which prevent the damage of normal healthy tissues. The introduction of various new radiopharmaceuticals and radioisotopes has significantly assisted the advancement of nuclear medicine. Ac-225 radiopharmaceuticals continuously demonstrate their potential as targeted alpha therapeutics. 225Ac-labeled radiopharmaceuticals have confirmed their importance in medical and clinical areas by introducing [225Ac]Ac-PSMA-617, [225Ac]Ac-DOTATOC, [225Ac]Ac-DOTA-substance-P, reported significantly improved response in patients with prostate cancer, neuroendocrine, and glioma, respectively. The development of these radiopharmaceuticals required a suitable buffer, incubation time, optimal pH, and reaction temperature. There is a growing need to standardize quality control (QC) testing techniques such as radiochemical purity (RCP). This review aims to summarize the development of the Ac-225 labeled compounds and biomolecules. The current state of their reported resulting clinical applications is also summarized as well. 相似文献
713.
714.
Angela H. Kim AB Masha Kolesnikova BS Wei Kiong Ngo MD Stephen H. Tsang MD PhD 《Clinical & experimental ophthalmology》2023,51(3):205-216
Hypoxia-inducible factor (HIF) plays a critical role in the mechanisms that allow cells to adapt to various oxygen levels in the environment. Specifically, HIF-1⍺ has shown to be widely involved in cellular repair, survival, and energy metabolism. HIF-1⍺ has also been found in increased levels in cancer cells, highlighting the importance of balance in the hypoxic response. Promoting HIF-1⍺ activity as a potential therapy for degenerative diseases and inhibiting HIF-1⍺ as a therapy for pathologies with overactive cell proliferation are actively being explored. Digoxin and metformin, HIF-1⍺ inhibitors, and deferoxamine and ⍺-ketoglutarate analogues, HIF-1⍺ activators, are being studied for application in age-related macular degeneration, diabetic retinopathy, and retinitis pigmentosa. However, these same medications have retinal toxicities that must be assessed before implementation of therapeutic care. Herein, we highlight the duality of therapeutic and toxic potential of HIF-1⍺ that must be carefully assessed prior to its clinical application in retinal disorders. 相似文献
715.